AAIPharma expands operations in central and eastern Europe

AAIPharma, a USA-based global provider of integrated solutions for the pharmaceutical industry, says that it is further expanding its operations in central and eastern Europe with the addition of an experienced team in Hungary. The new office is in Budapest and will initially consist of seven staff.

The US group already has two other offices in central and eastern Europe with established operations in Croatia and Russia. With the recent addition of an office in South Africa, it now has operations in 14 countries. "Central and Eastern Europe is one of most dynamic regions to run clinical trials," said Ludo Reynders, AAIPharma chief executive. The group in Hungary has therapeutic expertise in oncology, cardiovascular, respiratory, gastrointestinal and anti-infective clinical trials.